|
|
|
|
Office Locations:
|
4111 E 37th St. N
Wichita, KS 67220
| | |
|
|
|
- Early
- Expansion
- Growth
- Seed
|
|
|
|
Information Technology
Life Sciences & Healthcare
Manufacturing & Industrial
Software & Internet
|
|
|
|
KDT is a unique investment firm partnering with principled entrepreneurs who are building transformative companies. Koch Disruptive Technologies (KDT) focuses on partnering with high-growth companies that disrupt current market alternatives with demonstrated technology. KDT looks for opportunities to create mutual benefit by working with principled entrepreneurs who can receive significant value from interacting with Koch companies and whose technology has the potential to transform Koch's core capabilities, create new capabilities, or expand Koch into new platforms. Koch Labs is a strategic capability that connects portfolio entrepreneurs to Koch's diverse ecosystem of subject matter experts, businesses, and capabilities across Koch Industries
|
|
|
|
|
Investment Firm Key
VC = Venture Capital
PE = Private Equity
A = Angel
I = Incubator
MB = Merchant Bank
VD = Venture Debt
FI = Family Investment Office
FOF = Fund of Funds
ED = Economic Development Office
TT = Technology Transfer Office
CVC = Corporate Venture Capital
SEC = Secondary Purchaser
HF = Hedge Fund/Mutual Fund
|
|
| COMPANY STAGE | REVENUE |
| Venture Capital | |
Seed Stage
(includes "pre-seed," or
concept stage) | No Revenue |
| Early Stage | Minimal
Revenue |
Growth Stage
(also called Mid-stage) | $2M-$7M |
Expansion Stage
(also called Late-stage) | $7M and greater |
| Private Equity | |
| Lower Middle Market | $10M-$249M |
| Middle Market | $250M-$499M |
| Upper Middle Market | $500M-$1B |
| Large Cap | >$1B |
|
|
|
|
|
|
|
| Name | |
| |
Title | |
Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
|
| Brett Chugg | |
| |
Managing Director | |
| Chase Koch | |
| |
President | |
| Eli Groner | |
| |
Managing Director | |
|
|
|
|
Date
|
Name
|
State
|
Amount
|
Stage
|
04/16/2024
|
Rivos
|
CA
|
$250,000,000
|
Series A-3
|
03/27/2024
|
Celestial AI
|
CA
|
$175,000,000
|
Series C
|
08/23/2023
|
Cellares
|
CA
|
$255,000,000
|
Series C
|
06/28/2023
|
Celestial AI
|
CA
|
$100,000,000
|
Series B
|
06/12/2023
|
Percepto
|
|
$67,000,000
|
Series C
|
05/19/2023
|
Neura Health
|
NY
|
$8,000,000
|
Seed
|
05/10/2023
|
8fig
|
TX
|
$140,000,000
|
Series B
|
05/10/2023
|
8fig
|
TX
|
$140,000,000
|
Series B
|
05/09/2023
|
8fig
|
TX
|
$140,000,000
|
Series B
|
|
|
|
|
|
|
|
